The Optimization studies comprise the GMP validations, the regulatory dossiers and the clinical trials management. This second step of the co-development, tailored to each medical application, brings MedinCell and its partners to the drug market. Our delivery platform may help to extend the proprietary positions of drug franchises and might enable new claims with novel dosage forms.